STIFEL NICOLAUS & CO INC \MO\ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.

Quarter-by-quarter ownership
STIFEL NICOLAUS & CO INC \MO\ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2013$1,346,170,000
+40.3%
12,903
+15.8%
0.02%
+29.4%
Q2 2013$959,362,00011,1450.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2013
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,577,892$994,984,00031.62%
Ruane, Cunniff & Goldfarb 33,922,192$6,051,041,00031.06%
LeVasseur Capital Partners LLC 162,394$28,968,00029.76%
FARLEY CAPITAL L.P. 192,130$34,272,00027.18%
Pershing Square Capital Management 19,473,933$3,473,760,00024.90%
Arrow Capital Management, LLC 109,461$19,525,00016.53%
Marble Arch Investments 1,196,900$213,503,00016.43%
Tesuji Partners 1,368,040$244,414,00015.82%
ValueAct Holdings 14,994,261$2,674,676,00015.55%
Hound Partners 3,898,648$695,441,00015.04%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders